- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Thorazine
Synonyms :
Class :
Antipsychotics, Phenothiazine
Dosage forms & Strengths:
Adult:
Tablet:
10 mg
25 mg
50 mg
100 mg
200 mg
Injectable solution:
25mg/ml
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may have an increased QTc-prolonging effect when combined with chlorpromazine
may have an increased QTc-prolonging effect when combined with chlorpromazine
may have an increased QTc-prolonging effect when combined with chlorpromazine
may have an increased QTc-prolonging effect when combined with chlorpromazine
may have an increased QTc-prolonging effect when combined with chlorpromazine
when both drugs are combined, there may be an increase in qtc interval
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
It may enhance QTc interval when combined with pentamidine
may have an increased risk of adverse effects when combined with chlorpromazine
It may enhance QTc interval when combined with perphenazine
CNS depressants increase the effect of paraldehyde
may increase the QTc interval when combined
it increases the efficacy of CNS depressants
CNS depressants increase the efficacy of orphenadrine
glycopyrrolate inhaled and formoterol
may increase the QTc interval when combined
CNS depressants increase the effect of flunarizine
it increases the effect of CNS depressants
may decrease the therapeutic effect of cabergoline
may have an increased risk of adverse effects when combined with chlorpromazine
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines
antipsychotic Agents may enhance the adverse/toxic effect of amphetamines